Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy.

Smith S, Su D, Rigault de la Longrais IA, Schwartz P, Puopolo M, Rutherford TJ, Mor G, Yu H, Katsaros D.

J Clin Oncol. 2007 Nov 20;25(33):5172-9.

PMID:
18024864
2.

Expression of MDR1 in epithelial ovarian cancer and its association with disease progression.

Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Yu H.

Oncol Res. 2007;16(8):395-403.

PMID:
17913048
3.

IGF-II promoter methylation and ovarian cancer prognosis.

Beeghly AC, Katsaros D, Wiley AL, Rigault de la Longrais IA, Prescott AT, Chen H, Puopolo M, Rutherford TJ, Yu H.

J Cancer Res Clin Oncol. 2007 Oct;133(10):713-23. Epub 2007 Jun 14.

PMID:
17569086
4.

Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.

Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Schwartz P, Yu H.

Gynecol Oncol. 2006 Dec;103(3):990-5. Epub 2006 Jul 21.

PMID:
16859738
5.

Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential.

Wiley A, Katsaros D, Chen H, Rigault de la Longrais IA, Beeghly A, Puopolo M, Singal R, Zhang Y, Amoako A, Zelterman D, Yu H.

Cancer. 2006 Jul 15;107(2):299-308.

6.
7.

Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines.

Berruti A, Bitossi R, Gorzegno G, Bottini A, Generali D, Milani M, Katsaros D, Rigault de la Longrais IA, Bellino R, Donadio M, Ardine M, Bertetto O, Danese S, Sarobba MG, Farris A, Lorusso V, Dogliotti L.

Br J Cancer. 2005 Feb 28;92(4):634-8.

8.

Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma.

Katsaros D, Oletti MV, Rigault de la Longrais IA, Ferrero A, Celano A, Fracchioli S, Donadio M, Passera R, Cattel L, Bumma C.

Ann Oncol. 2005 Feb;16(2):300-6.

PMID:
15668288
9.

Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer.

Katsaros D, Cho W, Singal R, Fracchioli S, Rigault De La Longrais IA, Arisio R, Massobrio M, Smith M, Zheng W, Glass J, Yu H.

Gynecol Oncol. 2004 Sep;94(3):685-92.

PMID:
15350359
10.

Prognostic value of the human kallikrein gene 15 expression in ovarian cancer.

Yousef GM, Scorilas A, Katsaros D, Fracchioli S, Iskander L, Borgono C, Rigault de la Longrais IA, Puopolo M, Massobrio M, Diamandis EP.

J Clin Oncol. 2003 Aug 15;21(16):3119-26.

PMID:
12915603
11.

The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma.

Zhang L, Yang N, Katsaros D, Huang W, Park JW, Fracchioli S, Vezzani C, Rigault de la Longrais IA, Yao W, Rubin SC, Coukos G.

Cancer Res. 2003 Jul 15;63(14):4225-31.

12.

Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma.

BorgoƱo CA, Fracchioli S, Yousef GM, Rigault de la Longrais IA, Luo LY, Soosaipillai A, Puopolo M, Grass L, Scorilas A, Diamandis EP, Katsaros D.

Int J Cancer. 2003 Sep 10;106(4):605-10.

13.

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker.

Hoffman BR, Katsaros D, Scorilas A, Diamandis P, Fracchioli S, Rigault de la Longrais IA, Colgan T, Puopolo M, Giardina G, Massobrio M, Diamandis EP.

Br J Cancer. 2002 Sep 23;87(7):763-71.

14.

[Growth factors in epithelial ovarian cancer].

Piccinno R, Puopolo M, Rigault De La Longrais IA, Fracchioli S, Massobrio M, Katsaros D.

Minerva Ginecol. 2002 Feb;54(1):33-52. Review. Italian.

PMID:
11828269
15.

[Expression and prognostic significance in epithelial ovarian cancer].

Katsaros D, Yu H, Piccinno R, Puopolo M, Rigault De La Longrais IA, Fracchioli S, Massobrio M.

Minerva Ginecol. 2002 Feb;54(1):15-24. Italian.

PMID:
11828267
16.

Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients.

Obiezu CV, Scorilas A, Katsaros D, Massobrio M, Yousef GM, Fracchioli S, Rigault de la Longrais IA, Arisio R, Diamandis EP.

Clin Cancer Res. 2001 Aug;7(8):2380-6.

17.

Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.

Luo LY, Katsaros D, Scorilas A, Fracchioli S, Piccinno R, Rigault de la Longrais IA, Howarth DJ, Diamandis EP.

Clin Cancer Res. 2001 Aug;7(8):2372-9.

18.

[Chemoresistance in ovarian cancer. State of the art and future prospects].

Katsaros D, Fracchioli S, Arese P, Enria R, Cassinelli P, Mingrone K, Piccinno R, Rigault de la Longrais IA, Massobrio M.

Minerva Ginecol. 1999 Dec;51(12):483-99. Review. Italian.

PMID:
10767997

Supplemental Content

Loading ...
Support Center